Relationship between serum indicators, endothelial injury markers and renal damage in patients with ANCA-associated systemic vasculitis

Relationship between serum indicators, endothelial injury markers and renal damage in patients with ANCA-associated systemic vasculitis

Objective: To study the relationship between serum indicators, endothelial injury markers and renal damage in patients with ANCA-associated systemic vasculitis. Methods: Patients with ANCA-associated systemic vasculitis were selected for study, 30 cases of patients not complicated with renal damage...

Full description

Bibliographic Details
Main Authors:	Wei-Jia Liu, Jun-Bo Huang
Format:	Article
Language:	English
Published:	Editorial Board of Journal of Hainan Medical University 2016-05-01
Series:	Journal of Hainan Medical University
Subjects:	ANCA-associated systemic vasculitis Autoantibody Endothelial injury Renal damage
Online Access:	http://www.hnykdxxb.com/PDF/201610/12.pdf

Similar Items

Relation between duration of the prodromal phase and renal damage in ANCA-associated vasculitis
by: Eline Houben, et al.
Published: (2017-12-01)

ANCA-associated vasculitis overlaps with systemic sclerosis: a case report and literature review
by: Rui Wu, et al.
Published: (2021-03-01)

Methimazole-Induced ANCA Vasculitis: A Case Report
by: Precil Diego Miranda de Menezes Neves, et al.
Published: (2021-08-01)

Anaemia is an essential complication of ANCA-associated renal vasculitis: a single center cohort study
by: Tetsuya Kawamura, et al.
Published: (2017-11-01)

Rituximab in relapsing and de novo MPO ANCA-associated vasculitis with severe renal involvement: a case series
by: L. Caroti, et al.
Published: (2019-05-01)

Treatment-related damage in elderly-onset ANCA-associated vasculitis: safety outcome analysis of two nationwide prospective cohort studies
by: Ken-Ei Sada, et al.
Published: (2020-10-01)

Recommendations of the Brazilian Society of Rheumatology for the induction therapy of ANCA-associated vasculitis
by: Alexandre Wagner Silva de Souza, et al.

ANCA-associated vasculitis in a 14 years-old patient: a clinical case
by: A. V. Burlutskaya, et al.
Published: (2020-10-01)

ANCA-Associated Vasculitis: An Update
by: Salem Almaani, et al.
Published: (2021-04-01)

The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: A retrospective study
by: José Agapito Fonseca, et al.
Published: (2021-05-01)

The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: A retrospective study
by: José Agapito Fonseca, et al.
Published: (2021-05-01)

ANCA-associated vasculitis in childhood: recent advances
by: Marta Calatroni, et al.
Published: (2017-05-01)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
by: Zachary S. Wallace, et al.
Published: (2019-12-01)

Blue toe syndrome as the initial manifestation of ANCA-associated vasculitis
by: Marinchev Liubomir, et al.
Published: (2013-10-01)

Histopathological Findings Predict Renal Recovery in Severe ANCA-Associated Vasculitis Requiring Intensive Care Treatment
by: Samy Hakroush, et al.
Published: (2021-02-01)

Favorable efficacy of rituximab in ANCA-associated vasculitis patients with excessive B cell differentiation
by: Yusuke Miyazaki, et al.
Published: (2020-06-01)

ANCA vasculitis in a patient with Alport syndrome: a difficult diagnosis but a treatable disease!
by: Valentine Gillion, et al.
Published: (2017-03-01)

Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis
by: Gwen E. Thompson, et al.
Published: (2020-09-01)

Systematic Histological Scoring Reveals More Prominent Interstitial Inflammation in Myeloperoxidase-ANCA Compared to Proteinase 3-ANCA Glomerulonephritis
by: Samy Hakroush, et al.
Published: (2021-03-01)

Clinical value of determining the markers of vascular wall damage in patients with ANCA-associated vasculitis and polyarteritis nodosa
by: L. B. Petelytska, et al.
Published: (2020-02-01)

Hypocomplementemia is associated with more severe renal disease and worse renal outcomes in patients with ANCA-associated vasculitis: a retrospective cohort study
by: Aglaia Chalkia, et al.
Published: (2020-01-01)

Fatal pulmonary complication during induction therapy in a patient with ANCA-associated vasculitis
by: Brigita Jonaitytė, et al.
Published: (2016-07-01)

Ten-year experience with rituximab for induction and maintenance therapy in patients with ANCA-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2020-03-01)

Clinical and Renal Histology Findings and Different Responses to Induction Treatment Affecting the Long-Term Renal Outcomes of Children With ANCA-Associated Vasculitis: a Single-Center Cohort Analysis
by: Chen, Y., et al.
Published: (2022)

The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis
by: Sayo Takeda, et al.
Published: (2019-06-01)

Autoantibodies in systemic vasculitis
by: Alexandre Wagner Silva De Souza
Published: (2015-04-01)

Rituximab, Cyclophosphamide, and Corticosteroids for ANCA Vasculitis: The Good, the Bad, and the Ugly
by: Roberta Fenoglio, et al.
Published: (2020-10-01)

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
by: Frank B. Cortazar, et al.
Published: (2018-03-01)

Propylthiouracil-induced ANCA-negative cutaneous small vessel vasculitis
by: Aliaksandr Trusau, et al.
Published: (2018-01-01)

Relationship between serologic profile (ANCA type) and clinical features of renal involvement in ANCA-associated vasculitides
by: N M Bulanov, et al.
Published: (2018-06-01)

Chemokine/Cytokine Levels Correlate with Organ Involvement in PR3-ANCA-Associated Vasculitis
by: Janina Müller-Deile, et al.
Published: (2021-06-01)

Pathogenesis and pathology of anti-neutrophil cytoplasmic antibody（ANCA）-associated vasculitis
by: Daisuke Tsukui, et al.
Published: (2021-01-01)

A Case of Crescentic Glomerulonephritis Complicated with Hypocomplementemic Urticarial Vasculitis Syndrome and ANCA-Associated Vasculitis
by: Marenao Tanaka, et al.
Published: (2017-11-01)

Sequential development of ANCA‐associated vasculitis and anti‐GBM disease: A report of two cases
by: Camille Le Moine, et al.
Published: (2021-07-01)

Comprehensive Analysis of Sex Differences at Disease Manifestation in ANCA-Associated Glomerulonephritis
by: Désirée Tampe, et al.
Published: (2021-09-01)

The frequency of ANCA-associated vasculitis in a national database of hospitalized patients in China
by: Jiannan Li, et al.
Published: (2018-10-01)

Rituximab Induction and Maintenance in ANCA-Associated Vasculitis: State of the Art and Future Perspectives
by: Elena Treppo, et al.
Published: (2021-08-01)

Diagnostic and treatment challenge of unrecognized subacute bacterial endocarditis associated with ANCA-PR3 positive immunocomplex glomerulonephritis: a case report and literature review
by: D. Bele, et al.
Published: (2020-01-01)

GENETIC SUSCEPTIBILITY TO ANCA-ASSOCIATED VASCULITIS: STATE OF THE ART
by: Francesco eBonatti, et al.
Published: (2014-11-01)

The Role of Mycophenolate Mofetil for the Induction of Remission in ANCA-Associated Vasculitis: A Meta-Analysis
by: Anji Xiong, et al.
Published: (2021-03-01)